ABBV-1042 Clinical Trials (2026): 1 Studies for Healthy Volunteer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ABBV-1042 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Volunteer) and 48 total planned enrollment. 1 ABBV-1042 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07222709 (May 2026).
Where to Participate: All ABBV-1042 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting ABBV-1042trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| IL | Acpru /Id# 279405 | Grayslake60030 | NCT07222709 | Map |
ABBV-1042 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ABBV-1042 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07222709 | A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants | P1 | Healthy Volunteer | 48 | Oct 2025 |
All ABBV-1042 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07222709 | A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants | P1 | recruiting | 48 | AbbVie | Oct 2025 |
ABBV-1042 clinical trials: frequently asked questions
- How many ABBV-1042 clinical trials are there?
- 1 ABBV-1042 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ABBV-1042 clinical trials recruiting in 2026?
- Yes — 1 ABBV-1042 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is ABBV-1042 being studied for?
- ABBV-1042 is being studied for Healthy Volunteer. The trials are grouped by indication on this page.
- What phase is ABBV-1042 in?
- ABBV-1042 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ABBV-1042 clinical trials?
- The lead sponsor across the most ABBV-1042 trials is AbbVie. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ABBV-1042as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: